Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1990 Mar 31;300(6728):867–868. doi: 10.1136/bmj.300.6728.867

Thrombolysis and the general practitioner. 1. Practicable only under certain circumstances.

K A Fox 1
PMCID: PMC1662574  PMID: 2186828

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong A., Duncan B., Oliver M. F., Julian D. G., Donald K. W., Fulton M., Lutz W., Morrison S. L. Natural history of acute coronary heart attacks. A community study. Br Heart J. 1972 Jan;34(1):67–80. doi: 10.1136/hrt.34.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergmann S. R., Lerch R. A., Fox K. A., Ludbrook P. A., Welch M. J., Ter-Pogossian M. M., Sobel B. E. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med. 1982 Oct;73(4):573–581. doi: 10.1016/0002-9343(82)90338-2. [DOI] [PubMed] [Google Scholar]
  3. Burns J. M., Hogg K. J., Rae A. P., Hillis W. S., Dunn F. G. Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J. 1989 Apr;61(4):322–325. doi: 10.1136/hrt.61.4.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Leitch J. W., Birbara T., Freedman B., Wilcox I., Harris P. J. Factors influencing the time from onset of chest pain to arrival at hospital. Med J Aust. 1989 Jan 2;150(1):6–10. doi: 10.5694/j.1326-5377.1989.tb136310.x. [DOI] [PubMed] [Google Scholar]
  5. Rawles J. M., Haites N. E. Patient and general practitioner delays in acute myocardial infarction. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):882–884. doi: 10.1136/bmj.296.6626.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  7. Van de Werf F., Arnold A. E. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. 1988 Nov 26;297(6660):1374–1379. doi: 10.1136/bmj.297.6660.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES